Errors in pathology and laboratory medicine: Consequences and prevention

Journal of Surgical Oncology

Volumn 88, Issue 3, 2004, Pages 161-181

  Hollensead, Sandra C ^a   Lockwood, William B ^a   Elin, Ronald J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Errors; Laboratory medicine; Pathology; Quality improvement

Indexed keywords

AUTOPSY; CALIBRATION; CANCER GRADING; CANCER STAGING; CLINICAL EDUCATION; CLINICAL LABORATORY; COMPUTER SYSTEM; CONSULTATION; COST BENEFIT ANALYSIS; CYTOPATHOLOGY; GOOD LABORATORY PRACTICE; HEALTH CARE ORGANIZATION; HEMATOLOGY; HOSPITAL ADMINISTRATOR; HUMAN; IMAGING SYSTEM; LABORATORY TEST; MEDICAL AUDIT; MEDICAL DOCUMENTATION; MEDICAL ERROR; MEDICAL RECORD; MEDICAL STAFF; MICROBIOLOGY; MOLECULAR BIOLOGY; PAPANICOLAOU TEST; PATHOLOGY; PATIENT CARE; PATIENT SATISFACTION; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; TOTAL QUALITY MANAGEMENT; TRANSFUSION;

CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC ERRORS; HUMANS; LABORATORIES, HOSPITAL; LABORATORY TECHNIQUES AND PROCEDURES; MEDICAL ERRORS; PATHOLOGY, CLINICAL; QUALITY CONTROL;

EID: 10044282992     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20125     Document Type: Review

References (118)

1. Kohn L, Corrigan J, Donaldson M, editors: To err is human: Building a safer health system. Washington, DC: National Academies Press; 2000.
2. National Patient Safety Goals. Joint Commission on Accreditation of Healthcare Organization. 2004. www.jcaho.org/accredited+ organization/ patient+safety.
3. Goldschmidt HML, Lent RW: Gross errors and work flow analysis in the clinical laboratory. Klin Biochem Metab 1995;3:131-140.
4. Code of Federal Regulations. Title 42 CFR Parts 493 to end. Washington, DC: US Government Printing Office; 1998. (revised annually).
5. Food and Drug Administration. Guideline for quality assurance in blood establishments. Docket #91N-0450, Rockville, MD: CBER Office of Communication, Training, and Manufacturer's Assistance; 1995.
6. Quality program implementation. Association Bulletin 97-4. Bethesda, MD: American Association of Blood Banks; 1997.
7. Schlickman JJ: ISO 9000 quality management system design. Milwaukee, WI: ASQ Quality Press; 1998. pp 69-80.
8. Bonini P, Plebani M, Ceriotti F, et al.: Errors in laboratory medicine. Clin Chem 2002;48:691-698.
9. Barr JT: Clinical laboratory utilization: Rationale. In: Davis B, Mass D, Bishop M, eds.: Principles of clinical laboratory utilization and consultation. Philadelphia, PA: Saunders; 1999. p 6.
10. Wiwanitkit V: Types and frequency of pre-analytical mistakes in the first Thai ISO 9002:1994 certified clinical laboratory, a 6-month monitoring. BMC Clin Path 2001;1:5.
11. Stahl M, Lund ED, Brandslund I: Reasons for a laboratory's inability to report results for requested analytical tests. Clin Chem 1998;44:2195-2197.
12. Plebani M, Carraro P: Mistakes in a stat laboratory: Types and frequency. Clin Chem 1997;43:1348-1351.
13. Zarbo RJ, Schmidt WA, Bachner P, et al.: Indications and immediate patient outcomes of pathology intraoperative consultations. College of American Pathologists/Centers for Disease Control and Prevention Outcomes Working Group Study. Arch Pathol Lab Med 1996;120:19-25.
14. Ross JW, Boone DJ: Assessing the effect of mistakes in the total testing process on the quality of patient care (Abstract 102). In: Martin L, Wagner W, Essien JDK, editors. 1989 Institute of Critical Issues in Health Laboratory Practice. Minneapolis, MN: DuPont Press; 1991.
15. Moore SB, Foss ML: Error management: Theory and application in transfusion medicine at a tertiary-care institution. Arch Pathol Lab Med 2003;127:1517-1522.
16. ISO 9000 Compendium. 6th edn. Geneva, Switzerland: International Organization for Standardization; 1996.
17. Tsiakals J: A description of the quality hierarchy presented at the meeting of the AABB. Bethesda, MD: Accreditation Program Committee; 1996.
18. The quality program. Bethesda, MD: American Association of Blood Banks; 1994.
19. Technical Manual. Bethesda, MD: American Association of Blood Banks; 2002.
20. Sentinel events in the age of performance improvement. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1998.
21. Comprehensive accreditation manual for hospitals. Oakbrook Terrace, IL: Joint Commission on Accreditation for Healthcare Organizations; 1999.
22. American Association of Blood Banks. Bulletin, #97-4, August, 1997.
23. Menitove J, editor. Standards for blood banks and transfusion services, 18th edn. Bethesda, MD: American Association of Blood Banks; 1997.
24. Rossiter EB, editor. Regulatory resources information exchange. Richmond, VA: CITINGS; 2002.
25. Rossiter EB, editor. Regulatory resources information exchange. Richmond, VA: CITINGS; 2004.
26. Phillips-Donaldson DJ, editor. Shaping quality with six sigma. Quality Progress 2003;36:77-80.
27. Harry M: Six sigma: A breakthrough strategy for profitability. Quality Progress 1998;31:60-64.
28. Folan K: Six sigma: Striving for perfection. AABB Annual Meeting News. Bethesda, MD: American Association of Blood Banks; 2003. 3p.
29. Nolan T: A primer on leading improvement in health care. Amsterdam: Presented at the Fifth European Forum on Quality Improvement in Health Care; 2000.
30. Oakes D, Westcott RT: Quality management tools. In: ASQ Quality Management Division, editors. The Certified Quality Manager Handbook, 2nd edn. Milwaukee: American Society for Quality Press; 2001. pp 135-141.
31. Foster M: Process excellence in the laboratory environment. Transfusion Medicine Update, Winter 2002-2003; pp 8-9.
32. McFadden KL, Towell ER, Stock GN: Critical success factors for controlling and managing hospital errors. Qual Manag J 2004;11:61-73.
33. Bogdanich W: The Pap test misses much cervical cancer through lab's error. Wall Street J 1987; 1.
34. Bogdanich W: Physician's carelessness with Pap tests is cited in procedure's high failure rate. Wall Street J 1987; 17.
35. Davey DD: Papanicolaou smear 5-year retrospective review: What is required by the Clinical Laboratory Improvement Amendments of 1988? Arch Pathol Lab Med 1997;121:296-298.
36. Renshaw AA: Measuring and reporting errors in surgical pathology. Lessons from gynecologic cytology. Am J Clin Pathol 2001;115:338-341.
37. Hammond ME, Compton CC: Protocols for the examination of tumors of diverse sites: Introduction. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 2000;124:13-16.
38. Powsner SM, Costa J, Homer RJ: Clinicians are from Mars and pathologists are from Venus. Arch Path Lab Med 2000;124:1040-1046.
39. Foucar E: Error in anatomic pathology. Am J Clin Pathol 2001;116:S34-S46.
40. Travers H: Quality assurance indicators in anatomic pathology. Arch Pathol Lab Med 1990;114:1149-1156.
41. Azam M, Nakhleh RE: Surgical pathology extradepartmental consultation practices. Arch Pathol Lab Med 2002;126:405-412.
42. Leslie KO, Fechner RE, Kempson RL: Second opinions in surgical pathology. Am J Clin Pathol 1996;106:S58-S64.
43. Cramer SF, Roth LM, Mills SE, et al.: Sources of variability in classifying common ovarian cancers using the World Health Organization classification. Application of the pathtracking method. Pathol Annu 1993;28:243-286.
44. Schnitt SJ, Connolly JL, Tavassoli FA, et al.: Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-1143.
45. Page DL, Rogers LW: Carcinoma in situ (CIS). In: Page DL, Anderson TJ, editors. Diagnostic histopahtology of the breast. Edinburgh: Churchill Livingstone; 1987. pp 157-192.
46. Baak JPA, Oort J: A manual of morphometry in diagnostic pathology. New York: Springer-Verlag; 1983. pp 2-13.
47. Frable WJ: Needle aspiration biopsy: Past, present and future. Hum Pathol 1989;20:504-517.
48. Bartels PH: The diagnostic pattern in histopathology. Am J Clin Pathol 1989;91:S7-S13.
49. Singson RP, Natarajan S, Greenson JK, et al.: Virtual microscopy and the Internet as telepathology consultation tools. A study of gastrointestinal biopsy specimens. Am J Clin Pathol 1999;111:792-795.
50. Agha Z, Weinstein RS, Dunn BE: Cost minimization analysis of telepathology. Am J Clin Pathol 1999;112:470-478.
51. Lee ES, Kim IS, Jong SC, et al.: Accuracy and reproducibility of telecytology diagnosis of cervical smears. A tool for quality assurance programs. Am J Clin Pathol 2003;119:356-360.
52. Harrison JH, Jr., Stewart J III: Training in pathology informatics: Implementation at the University of Pittsburgh. Arch Pathol Lab Med 2003;127:1019-1025.
53. Henricks WH, Boyer PJ, Harrison JH, et al.: Informatics training in pathology residency programs: Proposed learning objectives and skill sets for the new millennium. Arch Pathol Lab Med 2003;127:1009-1018.
54. Spickard A, Jr., Gabbe SG, Christensen JF: Mid-career burnout in generalist and specialist physicians. JAMA 2002;288:1447-1450.
55. Kline TS: The challenge of quality improvement with the Papanicolaou smear. Arch Pathol Lab Med 1997;121:253-255.
56. Davey DD, Tritz DM: Communication and cytopathology - Part IV: Cytohistologic correlation and patient care. Diagn Cytopathol 1995;13:1-2.
57. Dodd LG, Sneige N, Villarreal Y, et al.: Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. Diagn Cytopathol 1993;9:138-144.
58. Joste NE, Crum CP, Cibas ES: Cytologic/histologic correlation for quality cervicovaginal cytology. Experience with 1,582 paired cases. Am J Clin Pathol 1995;103:32-34.
59. Cioc AM, Julius CJ, Proca DM, et al.: Cervical biopsy/cytology correlation data can be collected prospectively and shared clinically. Diagn Cytopathol 2002;26:49-52.
60. Morrell D, Curtis P, Mintzer M, et al.: Perceptions and opinions on the performance of Pap smears: A survey of clinicians using a commercial laboratory. Am J Prev Med 1996:12:271-276.
61. Fitzpatrick BT, Bibbo M: Superficial fine needle aspiration by clinicians: A survey of utilization. Am Surg 1996;62:719-723.
62. Nielsen ML: Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP). Arch Pathol Lab Med 1997;121:256-259.
63. Keenlyside RA, Collins CL, Hancock JS, et al.: Do proficiency test results correlate with the work performance of screeners who screen Papanicolaou smears? Am J Clin Pathol 1999;112:769-776.
64. Jones BA, Novis DA: Follow-up of abnormal gynecologic cytology: A college of American pathologists Q-probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med 2000;124:665-671.
65. Jones BA, Davey DD: Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med 2000;124:672-681.
66. Davey DD: Quality and liability issues with the Papanicolaou smear: The problem of definition of errors and false-negative smears. Arch Pathol Lab Med 1997;121:267-269.
67. Naryshkin S: The false-negative fraction for Papanicolaou smears: How often are "abnormal" smears not detected by a "standard" screening cytologist? Arch Pathol Lab Med 1997;121:270-272.
68. Stastny JF, Geisinger KR, Michael CW, et al.: Another quality assurance issue - Amended reports: What do we really know about them? Diagn Cytopathol 1998;18:67-70.
69. Derman H: Quality and liability issues with the Papanicolaou smear: Lessons from the science of error prevention. Arch Pathol Lab Med 1997;121:287-291.
70. Marshall CJ, Rowe L, Bentz JS: Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system. Diagn Cytopathol 1999;20:170-174.
71. Skoumal SM, Florell SR, Bydalek MD, et al.: Malpractice protection: Communication of diagnostic uncertainty. Diagn Cytopathol 1996;14:385-389.
72. Houwen B: Make no mistake. Advance/Laboratory 2003;12:32-43, www.advanceweb.com.
73. Astion ML, Shojania KG, Hamill TR, et al.: Classifying laboratory incident reports to identify problems that jeopardize patient safety. Am J Clin Pathol 2003;120:18-26.
74. Sunderman FW, Sr.: The history of proficiency testing/quality control. Clin Chem 1992;38:1205-1209.
75. Levey S, Jennings ER: The use of control charts in the clinical laboratories. Am J Clin Pathol 1950;20:1059-1066.
76. Westgard JO, Barry PL, Hunt MR, et al.: A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 1981;27:493-501.
77. McSwiney RR, Woodrow DA: Types of error within a clinical laboratory. J Med Lab Technol 1969;26:340-346.
78. Chambers AM, Elder J, O'Reilly DS: The blunder-rate in a clinical biochemistry service. Ann Clin Biochem 1986;23:470-473.
79. Lapworth R, Teal TK: Laboratory blunders revisited. Ann Clin Biochem 1994;31:78-84.
80. Witte DL, VanNess SA, Angstadt DS, et al.: Errors, mistakes, blunders, outliers, or unacceptable results: How many? Clin Chem 1997;43:1352-1356.
81. Kroll MH, Elin RJ: Interference with clinical laboratory analyses. Clin Chem 1994;40:1996-2005.
82. Munzenberger P: Emmanuel Sister. The incidence of drug-diagnostic test interferences in outpatients. Am J Hosp Pharm 1971;28:786-791.
83. Young DS: Effects of drugs on clinical laboratory tests, 5th edn. Washington, DC: AACC Press; 2000.
84. Narayanan S: The preanalytic phase. An important component of laboratory medicine. Am J Clin Pathol 2000;113:429-452.
85. Lundberg GD: The need for an outcomes research agenda for clinical laboratory testing. JAMA 1998;280:565-566.
86. Sandhaus LM, Meyer P: How useful are CBC and Reticulocyte Reports to clinicians? Am J Clin Pathol 2002;118:787-793.
87. Shahangian S, Stankovic AK, Lubin IM, et al.: Survey of hospital coagulation laboratory practices, United States-2001. Centers for Disease Control and Prevention 2003; http://www.phppo.cdc.gov/mlp/coag2001.asp.
88. Schifman RB, Strand CL, Meier FA, et al.: Blood culture contamination: A College of American Pathologists Q-probes study involving 640 institutions and 497134 specimens from adult patients. Arch Pathol Lab Med 1998;122:216-221.
89. Valenstein P, Meier F: Urine culture contamination: A College of American Pathologists Q-Probes study of contaminated urine cultures in 906 institutions. Arch Pathol Lab Med 1998;122:123-129.
90. Hofgártner WT, Tait JF: Frequency of problems during clinical molecular-genetic testing. Am J Clin Pathol 1999;112:14-21.
91. Denis JB: Lettre touchant deux experiences de la transfusion faites sur des homes. J Cusson, Paris 1667.
92. Blundell J: Experiments on the transfusion of blood by syringe. Med Chir Trans 1818;9:56-92.
93. Sazama K: Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583-590.
94. Center for Biologics Evaluation and Research and American Association of Blood Banks Annual Meeting (Internet). Rockville, MD: Center for Biologies Evaluation and Research; 2001. Available from: http://www.fda.gov/cber/meetings. htm.
95. Goodman C, Chan S, Collins P, et al.: Ensuring blood safety and availability in the US: Technological advances, costs, and challenges to payment - Final report. Transfusion 2003;43:3S-46S.
96. Boone DJ, Steindel SD, Herron R, et al.: Transfusion medicine monitoring practices. A study of the College of American Pathologists/Centers for Disease Control and Prevention Outcomes Working Group. Arch Pathol Lab Med 1995;119:999-1006.
97. Dzik WH, Murphy MF, Andreu G, et al.: Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society for Blood Transfusion. An international study of the performance of sample collection from patients. Vox Sang 2003;85:40-47.
98. Food and Drug Administration, Center for Biologies Evaluation and Research. Bar code label for human drug products and blood; proposed rule. 21 CFR parts 201, 606, and 610. Rockville, MD: Food and Drug Administration; 2003. Available from: http://www.fda.gov.
99. Wenz B, Mercuriali F, AuBuchon JP: Practical methods to improve transfusion safety by using novel blood unit and patient identification systems. Am J Clin Path 1997;107:S12-S16.
100. Turner CL, Casbard AC, Murphy XX: Barcode technology. It's role in increasing the safety of blood transfusion. Transfusion 2003;43:1200-1209.
101. Food and Drug Administration, Center for Biologies Evaluation and Research. Guideline for quality assurance in blood establishments. Rockville, MD: Food and Drug Administration; 1995. (Docket No. 91N-0450).
102. Food and Drug Administration, Center for Biologies Evaluation and Research. Draft guidance for industry: Biological product deviation reporting for blood and plasma establishments. Rockville, MD: Food and Drug Administration; 2001.
103. Transfusion Medicine Checklist. College of Pathology Accreditation Program, Chicago, 2003.
104. Guidance on implementation of new bacteria reduction and detecting systems. American Association of Blood Banks Bulletin. #03-10, August 29, 2003.
105. Aubuchon J: Evolution to the 21st century. In: Hillyer CD, et al.: editor. Blood banking and transfusion medicine. Basic principles & practice. Philadelphia: Churchill Livingston; 2003.
106. Juran JM: Juran on leadership for quality. New York: The Free Press; 1989.
107. Neave HR: The deming dimension. Knoxville, Tennessee: SPC Press; 1990.
108. Walton M: Deming management at work. New York: G.P. Putnam's Sons; 1991.
109. Nutting PA, Main DS, Fischer PM, et al.: Toward optimal laboratory use. Problems in laboratory testing in primary care. JAMA 1996;275:635-639.
110. Valenstein P, Meier F: Outpatient order accuracy: A College of American Pathologists Q-probes study of requisition order entry accuracy in 660 institutions. Arch Pathol Lab Med 1999;123:1145-1150.
111. Renner SW, Howanitz PJ, Bachner P: Wristband identification error reporting in 712 hospitals. A College of American Pathologists's Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med 1993;117:573-577.
112. Howanitz PJ, Valenstein PN, Fine G: Employee competence and performance-based assessment: A College of American Pathologists Q-probes study of laboratory personnel in 522 institutions. Arch Pathol Lab Med 2000;124:195-202.
113. Holman JW, Mifflin TE, Felder RA, et al.: Evaluation of an automated preanalytic robotic workstation at two academic health centers. Clin Chem 2002;48:540-548.
114. Howanitz PJ, Walker K, Bachner P: Quantification of errors in laboratory reports. A quality improvement study of the College of American Pathologists's Q-Probes program. Arch Pathol Lab Med 1992;116:694-700.
115. Howanitz PJ, Cembrowski GS: Postanalytical quality improvement: A College of American Pathologists Q-Probes study of elevated calcium results in 525 institutions. Arch Pathol Lab Med 2000;124:504-510.
116. Berwick DM: Errors today and errors tomorrow. N Engl J Med 2003;348:2570-2572.
117. Foucar E, Foucar K: Medical error. In: Bone marrow pathology, 2nd edn. Chicago: ASCP Press; 2001. pp 77-86.
118. ASCP news. ASCP Receives $150,000 CDC Cooperative Agreement. Lab Med 2004;35:28.